Literature DB >> 24250180

Twelfth cranial nerve involvement in Guillian Barre syndrome.

Subrat Kumar Nanda1, Sita Jayalakshmi, Devashish Ruikar, Mohandas Surath.   

Abstract

Guillian Barre Syndrome (GBS) is associated with cranial nerve involvement. Commonest cranial nerves involved were the facial and bulbar (IXth and Xth). Involvement of twelfth cranial nerve is rare in GBS. We present a case of GBS in a thirteen years old boy who developed severe tongue weakness and wasting at two weeks after the onset of GBS. The wasting and weakness of tongue improved at three months of follow up. Brief review of the literature about XIIth cranial nerve involvement in GBS is discussed.

Entities:  

Keywords:  Guillain Barre syndrome; tongue weakness; twelfth cranial nerve

Year:  2013        PMID: 24250180      PMCID: PMC3821433          DOI: 10.4103/0976-3147.118804

Source DB:  PubMed          Journal:  J Neurosci Rural Pract        ISSN: 0976-3155


Introduction

Guillian Barre Syndrome (GBS) is associated in 45-75% of cases with cranial nerve involvement. Facial nerve is the commonest to be involved followed by extra ocular muscles and lower cranial nerve involvement.[1] Twelfth cranial nerve involvement is extremely rare in GBS. Only two cases has been reported till date with GBS with total paresis of motor cranial nerves.[23] Here we present a case of GBS with XIIth nerve involvement.

Case Report

A thirteen year old boy presented with acute progressive areflexic flaccid quadriparesis associated with motor cranial nerve involvement with bilateral facial and bulbar weakness. He had an upper respiratory infection one week preceding the motor weakness which started from the lower limbs. On day seven after the onset of motor weakness of limbs, the child developed significant bulbar weakness, difficulty in talking and could not move the tongue. He was totally anarthric. On day nine, he had significant respiratory muscle weakness requiring mechanical ventilatory support. On day fourteen, bilateral tongue atrophy without fasciculations was noticed [Figure 1]. The nerve conduction studies (NCS) were suggestive of severe demyelinating motor sensory polyradiculoneuropathy. The facial nerve conductions revealed facial neuropathy. His anti-ganglioside antibody panel in the blood showed positive IgM GM2, GT1b, IgG GM1,2,3 and GT1b antibodies. His CSF showed albuminocytological dissociation and his Antinuclear antibody was negative. His magnetic resonance image (MRI) brain was normal. He was treated with intravenous immunoglobulin at a daily dose of 0.4 g/kg for five days. The child required prolonged ventilatory care for 22 days. He showed gradual improvement and started swallowing after eight weeks of the onset of illness. The wasting of the tongue also improved gradually at 3 months after the onset of illness [Figure 2]. At 6 months follow up, he was walking with support with residual bilateral foot drop. Repeat NCS was suggestive of motor sensory demyelinating radiculoneuropathy with improvement in conduction velocities and compound muscle action potential amplitudes compared to baseline study.
Figure 1

Tongue wasting noted at 2 weeks after the onset of motor weakness

Figure 2

Improvement in tongue weakness and wasting noted at 6 months

Tongue wasting noted at 2 weeks after the onset of motor weakness Improvement in tongue weakness and wasting noted at 6 months

Review of literature

Twelfth nerve involvement, either isolated or as a part of multiple cranial nerve involvement is quite uncommon and only two cases has been reported till date as a part of multiple motor cranial nerve involvement in a case of GBS. Tan et al., reported a case of fulminant GBS with quadriplegia and total paresis of motor cranial nerves and Polo et al., reported a case of atypical GBS with multiple cranial neuropathies including XIIth cranial nerve involvement.

Discussion

GBS with multiple cranial nerve involvement is a known entity but the involvement of XIIth cranial nerve is extremely rare. Our patient had multiple cranial neuropathies with involvement of VIIth, IXth, Xth and XIIth nerves. He had a severe form of GBS with areflexic quadriparesis along with respiratory muscle involvement requiring prolonged ventilatory support. His serial NCS showed sensory motor neuropathy of demyelinating type. His MRI brain was normal supporting that the tongue weakness is due to XIIth cranial nerve involvement. Twelfth nerve involvement, either isolated or as a part of multiple cranial nerve involvement is quite uncommon and only two cases has been reported till date as a part of multiple motor cranial nerve involvement in a case of GBS. Tan et al., reported a fulminant case of GBS with quadriparesis with all motor cranial nerve involvement and their NCS showed segmental demyelination which was responsible for such severe involvement and possibly the pathophysiology in this case and our case are similar.[2] Polo et al. described a 23 years gentleman who developed a progressive illness over ten days with diplopia, facial diplegia and a nasal voice.[3] Subsequently, the patient also developed weakness of the neck and tongue muscles, dysphagia, abolition of reflexes of the left arm and right triceps but without involvement of the respiratory muscles or other limbs. CSF studies showed slightly raised protein with no cells. Neurophysiological studies showed a demyelinating disorder with secondary axonal damage. However, the same patient had involvement of reflexes of left arm and right triceps only without involvement of respiratory muscles and lower limbs. Hence it was thought to an atypical variant of GBS in contrast to our case where he had all the typical features of GBS. Our patient showed anti-GM2 antibody positive which is usually seen in post CMV infection with or without GBS.[4] Anti-GT1b is usually associated with severe form of GBS.[5] usually going on to ventilatory support requirement and the same is found in our patient. The two previous case reports did not have the autoantibody levels to corroborate the clinical and electrophysiological findings. The cranial neuropathy in our patient showed gradual recovery and tongue atrophy recovered over next three months. At 6 months follow up he had shown good clinical and electrophysiological recovery.

Conclusion

GBS with multiple cranial nerve involvement can rarely involve the XIIth nerve as well causing significant tongue weakness and such a presentation may be indicative of a severe nature of the disease and it usually recovers over a period of time.
  4 in total

1.  Fulminant Guillain-Barré syndrome with quadriplegia and total paresis of motor cranial nerves as a result of segmental demyelination.

Authors:  A K Tan; M W Chee
Journal:  J Neurol Sci       Date:  1995-12       Impact factor: 3.181

2.  Acute cytomegalovirus infection and IgM anti-GM2 antibody.

Authors:  N Yuki; Y Tagawa
Journal:  J Neurol Sci       Date:  1998-01-21       Impact factor: 3.181

Review 3.  Antibodies against ganglioside complexes in Guillain-Barré syndrome and related disorders.

Authors:  Susumu Kusunoki; Ken-ichi Kaida
Journal:  J Neurochem       Date:  2011-01-07       Impact factor: 5.372

4.  [Atypical Guillain-Barré syndrome: multiple cranial neuropathy].

Authors:  J M Polo; M Alañá-García; P Cacabelos-Pérez; A Ortín-Castaño; J Ciudad-Bautista; J T López-Alburquerque
Journal:  Rev Neurol       Date:  2002 May 1-15       Impact factor: 0.870

  4 in total
  3 in total

Review 1.  COVID-19 Vaccination and the Rate of Immune and Autoimmune Adverse Events Following Immunization: Insights From a Narrative Literature Review.

Authors:  Naim Mahroum; Noy Lavine; Aviran Ohayon; Ravend Seida; Abdulkarim Alwani; Mahmoud Alrais; Magdi Zoubi; Nicola Luigi Bragazzi
Journal:  Front Immunol       Date:  2022-07-05       Impact factor: 8.786

2.  Commentary.

Authors:  Federico Pacei
Journal:  J Neurosci Rural Pract       Date:  2013-07

3.  Peroral endoscopic myotomy for treatment of Guillain-Barre syndrome-associated achalasia: A rare case.

Authors:  Seung Kak Shin; Kyoung Oh Kim; Eui Joo Kim; Su Young Kim; Jung Ho Kim; Yoon Jae Kim; Jun-Won Chung; Kwang An Kwon; Dong Kyun Park
Journal:  World J Gastroenterol       Date:  2017-02-07       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.